Lpl Financial LLC Bluebird Bio, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 86,077 shares of BLUE stock, worth $30,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,077

Previous 191,557 55.06%

Holding current value

$30,126

Previous $187,000 76.47%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.47 - $1.35 $49,575 - $142,398	-105,480 Reduced 55.06%	86,077 $44,000
Q2 2024 Aug 07, 2024	SELL	$0.85 - $1.26 $31,853 - $47,218	-37,475 Reduced 16.36%	191,557 $187,000
Q1 2024 May 10, 2024	BUY	$0.91 - $1.75 $183,960 - $353,769	202,154 Added 752.12%	229,032 $293,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $35,478 - $129,820	26,878 New	26,878 $37,000
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $126,832 - $236,964	-11,284 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $203,563 - $249,263	11,284 New	11,284 $361,000
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $319,532 - $500,226	-5,373 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$75.84 - $105.21 $6,370 - $8,837	84 Added 1.59%	5,373 $683,000
Q1 2019 May 08, 2019	BUY	$64.44 - $104.11 $22,940 - $37,063	356 Added 7.22%	5,289 $832,000
Q4 2018 Feb 07, 2019	BUY	$59.1 - $93.26 $1,122 - $1,771	19 Added 0.39%	4,933 $489,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $44,518 - $58,862	-501 Reduced 9.25%	4,914 $717,000
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $21,522 - $27,559	216 Added 4.15%	5,415 $850,000
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $12,801 - $18,263	-121 Reduced 2.27%	5,199 $888,000
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $432,250 - $695,323	5,320	5,320 $947,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Bluebird Bio, Inc. Transaction History